# Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage

> **NCT02091479** · PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 14 (actual)

## Conditions studied

- Major hæmorrhage

## Interventions

- **DRUG:** UFH Early group
- **DRUG:** UFH Late group

## Key facts

- **NCT ID:** NCT02091479
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** inclusion rate insufficient
- **Last updated:** 2016-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02091479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02091479, "Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02091479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*